右心室-肺动脉耦联预测二尖瓣反流术后生存
本回顾性研究评估TAPSE/PASP评估的右心室-肺动脉耦联对二尖瓣反流患者二尖瓣手术后生存和住院时间的预测价值。142例患者中,TAPSE/PASP≤0.35者全因死亡率更高(37% vs 8%),住院时间更长(9天 vs 7天),且为全因死亡的独立预测因子。
要点
- TAPSE/PASP≤0.35与二尖瓣术后全因死亡风险增加独立相关。
- TAPSE/PASP≤0.35者术后住院时间显著延长。
- 术前应评估右心室-肺动脉耦联以识别高危患者。
核心结论
- 在二尖瓣反流接受二尖瓣手术的患者中,TAPSE/PASP≤0.35与全因死亡率和住院时间增加相关。
研究设计与样本
- 回顾性分析,中位随访5.8年,纳入142例二尖瓣反流接受二尖瓣手术的患者,中位年龄67岁,女性49%。
主要发现
- 35例患者基线TAPSE/PASP≤0.35。
- TAPSE/PASP≤0.35组绝对死亡率37% vs 8%(P < 0.001),住院时间9天 vs 7天(P = 0.04)。
- Kaplan-Meier分析显示TAPSE/PASP≤0.35组生存率更低(log-rank P < 0.0001)。
- 多变量Cox回归中,TAPSE/PASP≤0.35是全因死亡的最显著预测因子(HR 3.69,95%CI 1.31-10.1,P = 0.011),此外还有慢性阻塞性肺疾病和估算肾小球滤过率。
- TAPSE/PASP≤0.35与住院时间显著增加相关(β 4.6,95%CI 0.66-8.5,P = 0.022),此外还有左心室射血分数、二尖瓣置换和急诊手术。
关键数值与推荐
- TAPSE/PASP≤0.35为预测全因死亡的最佳截点。
临床怎么用
- 术前可通过超声心动图测量TAPSE/PASP评估右心室-肺动脉耦联,识别二尖瓣手术后死亡和住院时间延长的高危患者。
局限性
- 回顾性设计,样本量有限,需在更大规模前瞻性队列中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Right ventricular-to-pulmonary artery coupling has been associated with outcomes in mitral regurgitation treated by transcatheter approaches. We evaluated right ventricular-to-pulmonary artery coupling as a predictor of survival and postoperative length of hospital stay (LOS) in patients with mitral regurgitation undergoing mitral valve surgery. METHODS: In this retrospective analysis (median follow-up: 5.8 years), right ventricular-to-pulmonary artery coupling was quantified as the ratio of tricuspid annular plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP) using transthoracic echocardiography. Receiver operating characteristic curve analysis was used to determine the optimum cut-point of TAPSE/PASP to predict all-cause mortality, and the study population was dichotomized according to this value. The primary end point was all-cause mortality. A secondary end point of LOS was also assessed. RESULTS: Out of 142 patients (median age: 67, female: 49%), 35 showed impaired coupling at baseline (TAPSE/PASP ≤0.35). Patients with TAPSE/PASP ≤0.35 had higher absolute mortality (37% vs 8%, P < 0.001) and longer LOS (7 days vs 9 days, P = 0.04). Kaplan-Meier analysis revealed lower survival in patients with TAPSE/PASP ≤0.35 (log-rank: P < 0.0001). In multivariable Cox regression, TAPSE/PASP ≤0.35 was the most significant predictor of all-cause mortality (hazard ratio: 3.69, 95% confidence interval 1.31-10.1, P = 0.011), alongside chronic obstructive pulmonary disease and estimated glomerular filtration rate. TAPSE/PASP ≤0.35 was associated with significantly increased LOS (β: 4.6, 95% confidence interval 0.66-8.5, P = 0.022) alongside left ventricular ejection fraction, mitral valve replacement and urgent operation. CONCLUSIONS: In mitral regurgitation patients undergoing mitral valve surgery, TAPSE/PASP ≤0.35 is associated with increased mortality and LOS. Further validation is indicated in larger, prospective cohorts.
引用
- Chehab O, Long E, Androshchuk V, et al. Right ventricular to pulmonary arterial coupling as a predictor of survival in patients undergoing mitral valve surgery for mitral regurgitation. Eur J Cardiothorac Surg. 2024. PMID: 39607781. doi:10.1093/ejcts/ezae421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。